Product Information
VENLAFAXINE HCL ER 37.5 MG CAP is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0850 per EA under NDC 70710169800. Its NADAC has been published 100 times since Jul 31, 2024.
Strength
37.5 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710169800
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090174On Market Since
5/18/2023
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has been published 100 times since Jul 31, 2024, and over the history we have for it it has risen 16.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0850 per EA |
|---|---|
| All-time high | $0.0954 (Oct 16, 2024) |
| All-time low | $0.0712 (Nov 20, 2024) |
| 52-week high | $0.0932 |
| 52-week low | $0.0850 |
| Median price | $0.0897 |
| Average price | $0.0881 |
| Largest weekly change | +28.7% (Aug 21, 2024) |
| Weeks tracked | 100 |
| Tracking since | Jul 31, 2024 |
Generic Alternatives
The matcher finds 11 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 37.5 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 37.5 MG CAP, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0850 per EA (NDC 70710169800), effective Jun 24, 2026.
How has the price of VENLAFAXINE HCL ER 37.5 MG CAP changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has risen 16.1%. It has been tracked across 100 weekly CMS publications since Jul 31, 2024.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 37.5 MG CAP?
Since Jul 31, 2024, the NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has ranged from a low of $0.0712 (Nov 20, 2024) to a high of $0.0954 (Oct 16, 2024), with a median of $0.0897 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 37.5 MG CAP?
Yes. 11 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, VENLAFAXINE HCL 37.5 MG TABLET, is $0.0795 per EA — about 6% below VENLAFAXINE HCL ER 37.5 MG CAP.
Who manufactures VENLAFAXINE HCL ER 37.5 MG CAP?
VENLAFAXINE HCL ER 37.5 MG CAP (NDC 70710169800) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification